On Thursday October 1st, Swiss HLG partnered with Gyrus Capital to host an engaging event on “Carve-outs in Pharma and Beyond”, bringing together investors, operators, and advisors to explore how carve-outs are increasingly shaping the life sciences landscape. The evening opened with a market update from Elsa Torchet and Igor Heinzer of Deloitte, who highlighted the forces reshaping the broader […]


